AOBO Launches New OTC Product To Treat Throat Inflammation

American Oriental Bioengineering, Inc. (NYSE: AOB), (“the Company” or “AOBO”), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter (“OTC”) products, announced that the Company has launched a new product called YuYeQingHuo Capsules (“YYQH”).

source : www.medicalnewstoday.com

Related News:

• UCLA School Of Dentistry To Build New Cancer Research Facility
• Elan revises J&J deal to appease Biogen
• MUHC/McGill researchers to WHO: Time to revise tuberculosis treatment guidelines
• Eli Lilly to cut 5,500 jobs by 2011
• New hospital, possible medical school attracting doctors to Merced
• Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG
• Three SE distinguished alumni to be honored at homecoming
• Geriatric expert to speak at fundraiser
• JHSPH To Lead Extremity Trauma Clinical Research Consortium
• Hospital mishaps linked to surgery deaths